Estrella Immunopharma, Inc. Earnings Per Share Diluted

Quick Answer

Estrella Immunopharma, Inc. reported Earnings Per Share Diluted of $0.35 (loss) per share for the year ending 2025.

  • Estrella Immunopharma, Inc. showed a decrease of -29.6% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Estrella Immunopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Estrella Immunopharma, Inc.'s Earnings Per Share Diluted has grown by 99.0%.
  • Historical annual values: Fiscal year 2025: $0.35 (loss) per share | Fiscal year 2024: $0.27 (loss) per share | Fiscal year 2023: $36.35 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: